We are excited about the recent launch of Eviti Connect® for autoimmune diseases, aimed at helping payers and providers realize...
Providers don’t want to delay patient care. Payers don’t want to waste money on unwarranted, ineffective autoimmune care. Both want...
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
As oncology costs continue to escalate and treatment decisions are more complex than ever, Eviti Connect empowers providers and payers...
NantHealth’s study data shows: Adoption of trastuzumab biosimilars in treatment of HER2-positive breast cancer is significant; does not appear to...
The COVID-19 pandemic has highlighted many existing cracks in our healthcare system and taken a tremendous toll on the entire...
Healthcare is an ever-evolving field that continues to grow and adapt based on research, the ability to analyze data, and...
For payers, Eviti Connect streamlines the authorization of cancer treatment, ensuring prescription of high-quality, high-value care and setting patients on...
Continued Relationships with Health Insurers Reflect the Need for High-quality, High-value Care as Cancer Treatments Become Increasingly Complex Culver City,...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
